Drug class in one race
CDK4 drugs for Non-Small Cell Lung Cancer
2 tracked CDK4 drugs in the Non-Small Cell Lung Cancer race. The class explanation lives on the CDK4 page; the full indication pipeline across every mechanism is on the Non-Small Cell Lung Cancer page.
1 Phase 21 preclinical / unstaged